Salim Yazji - 27 Jan 2022 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
27 Jan 2022
Net transactions value
+$16,900
Form type
4
Filing time
31 Jan 2022, 15:00:14 UTC
Previous filing
24 Jan 2022
Next filing
01 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $16,900 +10,000 +18% $1.69 67,137 27 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.